Business Description
Invitro International
NAICS : 325413
SIC : 2835
ISIN : US4618531036
Total Employee Number:
16Description
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 4.76 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 3.2 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 4.73 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -25 | |||||
3-Year Book Growth Rate | -31.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.97 | |||||
9-Day RSI | 30.14 | |||||
14-Day RSI | 29.69 | |||||
3-1 Month Momentum % | -3.83 | |||||
6-1 Month Momentum % | -42.75 | |||||
12-1 Month Momentum % | 42.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 12.42 | |||||
Quick Ratio | 10.93 | |||||
Cash Ratio | 9.99 | |||||
Days Inventory | 448.34 | |||||
Days Sales Outstanding | 26.89 | |||||
Days Payable | 10.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -23 | |||||
Shareholder Yield % | 4.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 81.88 | |||||
Operating Margin % | 8.7 | |||||
Net Margin % | 12.2 | |||||
EBITDA Margin % | 9.66 | |||||
FCF Margin % | 1.69 | |||||
OCF Margin % | 1.69 | |||||
ROE % | 6.05 | |||||
ROA % | 5.05 | |||||
ROIC % | 9.8 | |||||
3-Year ROIIC % | -125 | |||||
ROC (Joel Greenblatt) % | 14.23 | |||||
ROCE % | 3.82 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.4 | |||||
PE Ratio without NRI | 13.4 | |||||
PS Ratio | 1.87 | |||||
PB Ratio | 0.84 | |||||
Price-to-Tangible-Book | 0.84 | |||||
Price-to-Free-Cash-Flow | 67.01 | |||||
Price-to-Operating-Cash-Flow | 67.01 | |||||
EV-to-EBIT | 7.33 | |||||
EV-to-EBITDA | 6.6 | |||||
EV-to-Revenue | 0.64 | |||||
EV-to-FCF | 37.71 | |||||
Price-to-GF-Value | 1.34 | |||||
Price-to-Median-PS-Value | 1.68 | |||||
Price-to-Graham-Number | 0.74 | |||||
| Price-to-Net-Current-Asset-Value | 1.34 | |||||
| Price-to-Net-Cash | 1.68 | |||||
Earnings Yield (Greenblatt) % | 13.64 | |||||
FCF Yield % | 0.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IVRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Invitro International Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.828 | ||
| EPS (TTM) ($) | 0.005 | ||
| Beta | -0.8623 | ||
| 3-Year Sharpe Ratio | 0.4 | ||
| 3-Year Sortino Ratio | 0.79 | ||
| Volatility % | 97.16 | ||
| 14-Day RSI | 29.69 | ||
| 14-Day ATR ($) | 0.00319 | ||
| 20-Day SMA ($) | 0.077536 | ||
| 12-1 Month Momentum % | 42.17 | ||
| 52-Week Range ($) | 0.0315 - 0.16 | ||
| Shares Outstanding (Mil) | 22.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Invitro International Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Invitro International Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Invitro International Frequently Asked Questions
What is Invitro International(IVRO)'s stock price today?
The current price of IVRO is $0.07. The 52 week high of IVRO is $0.16 and 52 week low is $0.03.
When is next earnings date of Invitro International(IVRO)?
The next earnings date of Invitro International(IVRO) is .
Does Invitro International(IVRO) pay dividends? If so, how much?
Invitro International(IVRO) does not pay dividend.
Guru Commentaries on OTCPK:IVRO
No articles.
Press Release
Articles on Invitro International
No articles.